{"meshTagsMajor":["Mutation"],"meshTags":["Cyclin-Dependent Kinase Inhibitor p21","Extracellular Signal-Regulated MAP Kinases","Humans","Melanoma","Mutation","Protein Kinase Inhibitors","Proto-Oncogene Proteins B-raf","Proto-Oncogene Proteins c-akt","Proto-Oncogene Proteins p21(ras)","Skin Neoplasms"],"meshMinor":["Cyclin-Dependent Kinase Inhibitor p21","Extracellular Signal-Regulated MAP Kinases","Humans","Melanoma","Protein Kinase Inhibitors","Proto-Oncogene Proteins B-raf","Proto-Oncogene Proteins c-akt","Proto-Oncogene Proteins p21(ras)","Skin Neoplasms"],"genes":["RAS","BRAF"],"publicationTypes":["Letter","Research Support, Non-U.S. Gov\u0027t"],"title":"RAS mutations in benign epithelial tumors associated with BRAF inhibitor treatment of melanoma.","pubmedId":"25118623"}